No photo of Luigi Maria Oltrona Visconti

View Scopus Profile

Luigi Maria Oltrona Visconti

  • 2450 Citations
  • 22 h-Index
1981 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Luigi Maria Oltrona Visconti is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 26 Similar Profiles
Acute Coronary Syndrome Medicine & Life Sciences
Unstable Angina Medicine & Life Sciences
Registries Medicine & Life Sciences
clopidogrel Medicine & Life Sciences
Pulmonary Hypertension Medicine & Life Sciences
Percutaneous Coronary Intervention Medicine & Life Sciences
Myocardial Infarction Medicine & Life Sciences
Heart Failure Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1981 2019

Drug-eluting compared to bare metal stents in patients with end-stage renal disease on dialysis: a meta-analysis

Galiffa, V. A., Crimi, G., Gritti, V., Scotti, V., Ferrario, M., Repetto, A., Ferlini, M., Marinoni, B., De Ferrari, G. M., De Servi, S., Sante Bongo, A., Oltrona Visconti, L. & Klersy, C., May 1 2019, In : Journal of cardiovascular medicine (Hagerstown, Md.). 20, 5, p. 313-320 8 p.

Research output: Contribution to journal › Article

Chronic Kidney Failure
Stents
Meta-Analysis
Dialysis
Drug-Eluting Stents

Early Complete Revascularization in Hemodynamically Stable Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease

Fortuni, F., Crimi, G., Angelini, F., Leonardi, S., D'Ascenzo, F., Ferlini, M., Rolando, M., Raisaro, A., Oltrona Visconti, L., Ferrario, M., Gnecchi, M. & De Ferrari, G. M., Aug 1 2019, In : Canadian Journal of Cardiology. 35, 8, p. 1047-1057 11 p.

Research output: Contribution to journal › Review article

Confidence Intervals
Safety
Angiography
Randomized Controlled Trials
Myocardial Infarction

È necessario prescrivere, e per quanto tempo, la terapia anticoagulante orale nel paziente con fibrillazione atriale parossistica in corso di sindrome coronarica acuta?

Translated title of the contribution: Is it necessary to prescribe oral anticoagulant therapy for paroxysmal atrial fibrillation during acute coronary syndrome, and for how long?Visconti, L. O., Ferlini, M., Rordorf, R. & Savastano, S., Jun 1 2019, In : Giornale italiano di cardiologia (2006). 20, 6, p. 361-366 6 p.

Research output: Contribution to journal › Article

Acute Coronary Syndrome
Anticoagulants
Atrial Fibrillation
clopidogrel
Guidelines

Favorable effect of glycoprotein IIbIIIa inhibitors among STEMI patients treated with primary PCI and incomplete ST resolution

Somaschini, A., Cornara, S., Ferlini, M., Crimi, G., Camporotondo, R., Gnecchi, M., Ferrario Ormezzano, M., Oltrona Visconti, L., De Ferrari, G. M. & De Servi, S., Jan 1 2019, (Accepted/In press) In : Platelets.

Research output: Contribution to journal › Article

Glycoproteins
Percutaneous Coronary Intervention
Mortality
Propensity Score
ST Elevation Myocardial Infarction

How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post-MI Study

on behalf of the EYESHOT Post-MI Investigators, Nov 1 2019, In : Clinical Cardiology. 42, 11, p. 1113-1120 8 p.

Research output: Contribution to journal › Article

Open Access